Progress in western and traditional Chinese medicine treatment of epilepsy

ZHU Dongyu; LU Zhengyu; LU Lingdan; XU Qiang; ZHAO Hong

doi:10.12022/jnnr.2017-0052

PDF(1657 KB)

Journal of Neurology and Neurorehabilitation ›› 2017, Vol. 13 ›› Issue (4) : 221-226. DOI: 10.12022/jnnr.2017-0052

Review

Progress in western and traditional Chinese medicine treatment of epilepsy

ZHU Dongyu1, LU Zhengyu1, LU Lingdan1, XU Qiang2, ZHAO Hong1

Author information +

History +

Abstract

Epilepsy is a chronic brain disease caused by a variety of reasons. It is a kind of repetitive, episodic and transient central nervous system dysfunction which is caused by the excessive discharge of neurons in the brain. Epilepsy is one of the common diseases of nervous system. There are about fifty million persons with epilepsy in the world. In China, there are about six million patients with active epilepsy, and the treatment gap is up to 63%. Recurrent seizures will seriously affect the quality of life of patients. The majority of patients can reach effective control of the seizures through reasonable medication treatment, whereas a part of patients with refractory epilepsy need non-drug therapy. This article summarizes the progress in treatment of epilepsy from two aspects of western medicine and traditional Chinese medicine.

Key words

Epilepsy / Western medicine treatment / Traditional Chinese medicine treatment

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHU Dongyu, LU Zhengyu, LU Lingdan, XU Qiang, ZHAO Hong. Progress in western and traditional Chinese medicine treatment of epilepsy[J]. Journal of Neurology and Neurorehabilitation. 2017, 13(4): 221-226 https://doi.org/10.12022/jnnr.2017-0052

References

[1] 李世绰, 洪　震, 吴　逊, 等. 临床诊疗指南癫痫分册[M]. 北京: 人民卫生出版社, 2015:11.
[2] 肖花明, 王　毅. 癫痫的药物治疗研究进展[J]. 世界临床药物, 2012, 33(1):22-24, 29.
[3] 吕传真, 洪　震, 董　强. 神经病学[M]. 上海: 上海科学技术出版社, 2015:359-361.
[4] PERUCCA E. Marketed new antiepileptic drugs: are they better than old-generation agents?[J]. Ther Drug Monit, 2002, 24(1):74-80.
[5] JACOB S, NAIR AB. An updated overview on therapeutic drug monitoring of recent antiepileptic drugs[J]. Drugs R D, 2016, 16(4):303-316.
[6] 吴冬燕, 朱国行. 抗癫痫药物的分类、作用机制与不良反应[J]. 上海医药, 2015, 36(9):3-7.
[7] 吕梦娜, 张　洪. 难治性癫痫持续状态研究进展[J]. 中华实用诊断与治疗杂志, 2015, 29(3):212-214.
[8] 孙宇丹, 刘　毅. 难治性癫痫的中西医研究进展[J]. 陕西中医, 2017, 38(2):269-271.
[9] 周卫忠, 刘丽莉, 王　丽, 等. 脑电定位显微外科手术治疗难治性颞叶癫痫临床观察[J]. 河北医学, 2014, 20(5):809-811.
[10] RAMANTANI G, KADISH NE, BRANDT A, et al. Seizure control and developmental trajectories after hemispherotomy for refractory epilepsy in childhood and adolescence[J]. Epilepsia, 2013, 54(6):1046-1055.
[11] DALIC L, COOK MJ. Managing drug-resistant epilepsy: challenges and solutions[J]. Neuropsychiatr Dis Treat, 2016, 12:2605-2616.
[12] ENGLOT DJ, BIRK H, CHANG EF. Seizure outcomes in nonresective epilepsy surgery: an update[J]. Neurosurg Rev, 2017, 40(2):181-194.
[13] KOWSKI AB, VOGES J, HEINZE HJ, et al. Nucleus accumbens stimulation in partial epilepsy－a randomized controlled case series[J]. Epilepsia, 2015, 56(6):78-82.
[14] VAN COMPEL JJ, KLASSEN BT, WORELL GA, et al. Anterior nuclear deep brain stimulation guided by concordant hippocampal recording[J/OL]. Neurosurg Focus, 2015, 38(6):E9(2015-03-11)[2017-11-21]. DOI: 10.3171/2015.3.FOCUS1541.
[15] MORRELL MJ, HALPERN C. Responsive direct brain stimulation for epilepsy[J]. Neurosurg Clin N Am, 2016, 27(1):111-121.
[16] TUNG JK, BERGLUND K, GROSS RE. Optogenetic approaches for controlling seizure activity[J]. Brain Stimul, 2016, 9(6):801-810.
[17] KALAPOS MP. Possible mechanism for the effect of ketogenic diet in cases of uncontrolled seizures. The reconsideration of acetone theory[J]. Med Hypotheses, 2007, 68(6):1382-1388.
[18] 王　薇, 孙素真, 陈　芳, 等. 癫痫患儿应用生酮饮食治疗的效果观察[J]. 现代生物医学进展, 2016, 16(12):2300-2302.
[19] KANTER-SCHLIFEK I, GEORGIEVSKA B, KIRIK D, et al. Seizure suppression by GDNF gene therapy in animal models of epilepsy[J]. Mol Ther, 2007, 15(6):1106-1113.
[20] HOSFORD BE, LISKA JP, DANZER SC. Ablation of newly generared hippocampal granule cell has disease-modifying effects in epilepsy[J]. J Neurosci, 2019, 36(43):11013-11023.
[21] SHETTY AK, UPADHYA D. GABA-ergie cell therapy for epilepsy: aavances, limitations and challenges[J]. Neurosci Biobehave Rev, 2016, 62:35-47.
[22] 李　慧, 戴园园, 李　蕊, 等. 神经干细胞移植对发育期癫痫大鼠的影响[J]. 江苏医药, 2016, 42(11):1214-1217.
[23] 周仲英. 中医内科学[M]. 北京:中国中医药出版社, 2007:163-164.
[24] 孔美珠, 陈少玫. 中医药治疗癫痫的研究进展[J]. 中医药通报, 2013, 12(1):63-65, 53.
[25] 姚奇志, 邓楚欣. 从“伏气学说”探讨特发性癫痫的病因病机及辨证治疗[J]. 上海中医药杂志, 2015, 49(12):26-28.
[26] 戚拥军, 赵晓忠, 国春玲. 中西医治疗小儿癫痫的疗效观察[J].中外医疗, 2013, 32(29):136-137.
[27] 刘玉鹏. 化痰祛风逐瘀方对癫痫患者发作的临床疗效[J]. 陕西中医, 2016, 37(4):465-467.
[28] 周　洋, 陆征宇, 李　辛, 等. 化痰息风方对癫痫患者认知功能与生活质量的影响[J]. 中国中医急症, 2015, 24(6):962-964, 995.
[29] 孙峰华, 傅　毅. 草果知母汤对印防己毒点燃癫痫大鼠在水迷宫中学习记忆能力的影响[J]. 浙江中医杂志, 2015, 50(3):171-173.
[30] 王　倩, 范文涛. 加味柴胡龙骨牡蛎汤对戊四唑点燃型模型大鼠癫痫发作的影响[J]. 中国实验方剂学杂志, 2011, 17(5):202-203.
[31] 何绘敏, 路　晴, 孙香梅, 等. 不同抗癫痫药物对幼年癫痫大鼠海马胶质原纤维酸性蛋白的影响[J]. 大连医科大学学报, 2014, 36(2):120-123.
[32] 李海峰, 石若娜, 韩文静, 等. 石菖蒲药理作用及其机制的研究进展[J]. 时珍国医国药, 2016, 27(11):2728-2730.
[33] 谢　炜, 陈伟军, 孟春想, 等. 柴胡皂苷a对难治性癫痫大鼠多药耐药蛋白P-糖蛋白表达的影响[J]. 中国实验方剂学杂志, 2013, 19(9):229-232.
[34] 孙丹丹, 王丹巧. 川芎嗪对脑、脊髓损伤的保护作用及其机制研究进展[J]. 中国生化药物杂志, 2014, 34(4):179-183.
[35] 申　梅, 陶　杰, 徐　侃. 单味中药及单体有效成分对抗癫痫机理实验研究简况[J]. 实用中医内科杂志, 2017, 31(4):79-82.
[36] 林　青, 刘素芝, 张玲玲, 等. 姜黄素对匹罗卡品致痫大鼠海马S100B蛋白表达的影响[J]. 中华中医药学刊, 2014, 32(12):2977-2979.
[37] 那尔布力·巴合提别克, 张晓英, 景福权, 等. 头针配合康复治疗小儿癫痫疗效观察[J]. 上海针灸杂志, 2017, 36(10):1199-1202.
[38] 杨志林. 中药结合针灸治疗儿童癫痫的临床分析[J]. 当代医学, 2013, 19(14):156-157.
[39] 李明娟. 头针治疗小儿癫痫的临床观察和护理[J]. 护理研究, 2013, 27(2):152-153.
[40] 杨海龙, 乔丽娜, 谭连红, 等. 耳穴区经皮电刺激对颞叶癫痫大鼠癫痫发作频率及海马区白介素-1β、肿瘤坏死因子-α表达的影响[J]. 针刺研究, 2016, 41(4):283-290.
[41] 张　艳, 柯玲玲, 刘国成, 等. 脑电图引导下针刺治疗癫痫的临床观察[J]. 上海针灸杂志, 2017, 36(10):1190-1195.

Funding

National Natural Science Foundation of China (No. 81503551); Natural Science Foundation of Shanghai (No. 15ZR1442300); Medical Pilot Science and Technology Project of Shanghai Science and Technology Commission (No. 15401930200); Shanghai Disease Prevention and Health Care Service System Construction Project on Preventive Treatment of Diseases (No. ZY3-FWMS-1-1001-KYJS-13); Shanghai 3-year Action Plan on Further Accelerating the Development of Traditional Chinese Medicine (No. ZY3-RCPY-3-1030); Shanghai Municipal Fund for Talent Development (No. 201456); Shanghai Pujiang Talent Plan (No. 17PJD039); Training Program for Potential Medical Experts and Young Nursing Talents in Shanghai University of Traditional Chinese Medicine